共 50 条
Recent advances in head and neck squamous cell carcinoma - A review
被引:32
|作者:
Safdari, Yaghoub
[1
]
Khalili, Masoumeh
[3
]
Farajnia, Safar
[2
]
Asgharzadeh, Mohammad
[4
]
Yazdani, Yaghoub
[5
]
Sadeghi, Mahnaz
[1
]
机构:
[1] Tabriz Univ Med Sci, Biotechnol Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
[3] Mazandaran Univ Med Sci, Sch Pharm, Pharmaceut Sci Res Ctr, Sari, Iran
[4] Tabriz Univ Med Sci, Paramed Fac, Tabriz, Iran
[5] Golestan Univ Med Sci, Fac Adv Med Sci Technol, Gorgan, Iran
关键词:
Head and neck cancer;
EGFR;
Apoptosis;
Radiosensitivity;
Cetuximab;
Erlotinib;
GROWTH-FACTOR RECEPTOR;
CANCER CELLS;
ACQUIRED-RESISTANCE;
DNA-REPAIR;
CYCLIN D1;
EGFR;
INHIBITOR;
APOPTOSIS;
CETUXIMAB;
INVASION;
D O I:
10.1016/j.clinbiochem.2014.05.066
中图分类号:
R446 [实验室诊断];
R-33 [实验医学、医学实验];
学科分类号:
1001 ;
摘要:
The current review presents the results of the most recent studies performed on different aspects of human head and neck squamous cell carcinoma, including radiosensitivity induction, efficiency improvement of monoclonal antibodies using low-intensity ultrasound, chemical compounds such as toll-like receptor (TLC) agonists, dasatinib, resveratrol and niclosamide, nuclear inhibition of cancer using STAT3 decoy oligonucleotide, efficiency of anti-EGFR monoclonal antibodies in detection of head and neck cancers and other related issues. (C) 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
下载
收藏
页码:1195 / 1202
页数:8
相关论文